Literature DB >> 1091644

Ribonucleic acid processing activity of Escherichia coli ribonuclease III.

H D Robertson, J J Dunn.   

Abstract

We have studied the nuclease activities present in preparations of Escherichia coli RNase III and the "sizing factor" responsible for specific processing of several RNA species. RNase III preparations contain three activities: one which solubilizes stable RNA:RNA duplexes; one which solubilizes the RNA of DNA:RNA hybrids; and one which processes the polycistronic mRNA of bacteriophage T7 in a manner identical with sizing factor. We show that the activity against the RNA of DNA:RNA hybrids can be removed, but that the activity which cleaves RNA:RNA duplexes and that responsible for specific processing of phage T7 polycistronic mRNA appear to be identical by several biochemical criteria. In addition, partially purified enzyme fractions from mutants lacking these two activities contain substantial amounts of activity against the RNA of DNA:RNA hybrids. We have also defined several properties of the two activities solubilize RNA:RNA duplexes and RNA of DNA:RNA hybrids. Average oligonucleotide chain length in an exhaustive digest of double-stranded RNA is about 15 bases, while that in a digest of the RNA in DNA:RNA hybrids is less than 10 bases. Direct analysis shows that both activities cleave RNA chains to yield 5'-phosphate and 3'-hydroxyl termini. All four bases can reside at the 5' end of the resulting oligonucleotides, although both activities show a mild preference for certain bases. These results and previous findings allow us to specify the probably size and structure of potential cleavage sites for these enzymes in biological RNA molecules.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091644

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Cleavage of adenovirus messenger RNA and of 28S and 18S ribosomal RNA by RNase III.

Authors:  H Westphal; R J Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  Short RNA duplexes guide sequence-dependent cleavage by human Dicer.

Authors:  Lucien Bergeron; Jean-Pierre Perreault; Sherif Abou Elela
Journal:  RNA       Date:  2010-10-25       Impact factor: 4.942

3.  Longer-than-unit-length viroid minus strands are present in RNA from infected plants.

Authors:  A D Branch; H D Robertson; E Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  The cleavage specificity of RNase III.

Authors:  L Krinke; D L Wulff
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

5.  An Arabidopsis RNase III-like protein, AtRTL2, cleaves double-stranded RNA in vitro.

Authors:  Eri Kiyota; Ryo Okada; Naoko Kondo; Akihiro Hiraguri; Hiromitsu Moriyama; Toshiyuki Fukuhara
Journal:  J Plant Res       Date:  2010-10-27       Impact factor: 2.629

6.  The isolation and characterization of bacteriophage T7 messenger RNA fragments containing an RNase III cleavage site.

Authors:  R A Kramer; M Rosenberg
Journal:  Nucleic Acids Res       Date:  1976-10       Impact factor: 16.971

7.  Ribonuclease P substrate specificity: cleavage of a bacteriophage phi80-induced RNA.

Authors:  A L Bothwell; B C Stark; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

8.  Complementary sequences 1700 nucleotides apart form a ribonuclease III cleavage site in Escherichia coli ribosomal precursor RNA.

Authors:  R A Young; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Structural features of Bacillus precursor 5S RNA involved in the interaction with RNAase M5.

Authors:  W J Stiekema; H A Raué; M M Duin; R J Planta
Journal:  Nucleic Acids Res       Date:  1980-11-25       Impact factor: 16.971

10.  Cleavage of T4 species I ribonucleic acid by Escherichia coli ribonuclease III.

Authors:  G V Paddock; K Fukada; J Abelson; H D Robertson
Journal:  Nucleic Acids Res       Date:  1976-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.